FilingSEC EDGAR6-K
SciSparc Subsidiary NeuroThera Expands Patent Portfolio for Psychedelic Combinations
· SEC accepted
StagePatent Application
Filing content
SciSparc announced that its subsidiary NeuroThera has expanded its U.S. patent portfolio through a collaboration with Clearmind, covering combinations of LSD, ketamine, and ibogaine.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…